Gene expression profiling of Group 3 medulloblastomas defines a clinically tractable stratification based on KIRREL2 expression

Medulloblastomas (MB) molecularly designated as Group 3 (Grp 3) MB represent a more clinically aggressive tumor variant which, as a group, displays heterogeneous molecular characteristics and disease outcomes. Reliable risk stratification of Grp 3 MB would allow for appropriate assignment of patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Korshunov, Andrey, Okonechnikov, Konstantin, Stichel, Damian, Schrimpf, Daniel, Delaidelli, Alberto, Tonn, Svenja, Mynarek, Martin, Sievers, Philipp, Sahm, Felix, Jones, David T. W., von Deimling, Andreas, Pfister, Stefan M., Kool, Marcel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288368/
https://www.ncbi.nlm.nih.gov/pubmed/35771282
http://dx.doi.org/10.1007/s00401-022-02460-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288368/
https://www.ncbi.nlm.nih.gov/pubmed/35771282
http://dx.doi.org/10.1007/s00401-022-02460-1

Ejemplares similares